NASDAQ:ETTX
Entasis Therapeutics Holdings Inc.
- Stock
Last Close
2.19
19/08 20:00
Volume Today
68.83K
Avg: -
PE Ratio
−2.20
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 1.56M - | 1.79M 15.15% | 1.34M 25.47% | 982K 26.55% | 921.50K 6.16% | ||
average receivables | 478K - | 1.21M 153.97% | 1.47M 21.00% | 1.56M 6.26% | 945K 39.46% | ||
book value per share | -7.09 - | -15.01 111.78% | 24.24 261.43% | 3.20 86.78% | 2.17 32.16% | 0.66 69.64% | |
capex per share | -0.04 - | -0.08 104.29% | -0.11 40.58% | -0.01 92.63% | -0.00 90.62% | -0.00 97.78% | |
capex to depreciation | -0.79 - | -1.47 86.38% | -2.26 53.04% | -0.74 67.22% | -0.13 82.74% | -0.67 427.24% | |
capex to operating cash flow | 0.01 - | 0.01 20.00% | 0.01 1.90% | 0.00 77.28% | 0.00 83.11% | 0.00 311.10% | |
capex to revenue | -0.07 - | -0.01 79.73% | |||||
cash per share | 7.07 - | 14.83 109.86% | 24.88 67.80% | 3.12 87.48% | 2.21 28.96% | 0.68 69.14% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | 124.54 - | 64.24 48.42% | |||||
debt to assets | 1.97 - | 1.95 1.23% | 0.07 96.33% | 0.17 142.98% | 0.15 13.44% | 0.24 57.56% | |
debt to equity | -2.03 - | -2.05 1.30% | 0.08 103.75% | 0.21 173.08% | 0.18 15.82% | 0.31 75.46% | |
dividend yield | |||||||
earnings yield | -0.48 - | -0.76 56.71% | -2.37 213.41% | -0.67 71.68% | -0.85 26.74% | -0.45 46.45% | |
enterprise value | 13.36M - | -15.49M 215.98% | -35.44M 128.81% | 51.20M 244.46% | 7.50M 85.34% | 71.30M 850.23% | |
enterprise value over ebitda | -0.71 - | 0.52 173.80% | 1.10 110.50% | -1.19 208.49% | -0.15 87.48% | -1.52 917.26% | |
ev to operating cash flow | -0.84 - | 0.57 168.12% | 0.99 73.50% | -1.14 215.64% | -0.17 85.56% | -1.66 904.49% | |
ev to sales | -7.09 - | 7.31 203.19% | |||||
free cash flow per share | -4.33 - | -7.39 70.54% | -10.58 43.27% | -3.41 67.80% | -1.89 44.58% | -0.91 51.83% | |
free cash flow yield | -0.41 - | -0.69 70.54% | -2.60 275.26% | -0.69 73.63% | -0.76 11.52% | -0.42 45.67% | |
graham net net | -7.26 - | -15.86 118.46% | 23.39 247.45% | 2.51 89.26% | 1.89 24.86% | 0.48 74.68% | |
graham number | 28.63 - | 52.16 82.17% | 72.49 38.99% | 15.50 78.62% | 10.13 34.63% | 3.85 62.04% | |
income quality | 0.84 - | 0.91 8.64% | 1.09 19.76% | 1.02 6.13% | 0.90 11.84% | 0.91 1.33% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | |||||||
interest debt per share | 0.04 - | 0.05 42.80% | |||||
inventory turnover | |||||||
invested capital | 0.01 - | 0.03 110.48% | |||||
market cap | 39.61M - | 39.61M 0% | 13.92M 64.86% | 65.41M 369.94% | 59.43M 9.14% | 103.61M 74.34% | |
net current asset value | -26.77M - | -58.26M 117.65% | 82.40M 241.43% | 40.13M 51.30% | 50.86M 26.75% | 30.11M 40.81% | |
net debt to ebitda | 1.39 - | 1.85 33.54% | 1.53 17.59% | 0.33 78.38% | 1.03 212.34% | 0.69 33.39% | |
net income per share | -5.14 - | -8.05 56.71% | -9.64 19.66% | -3.33 65.42% | -2.10 37.01% | -1.00 52.52% | |
operating cash flow per share | -4.29 - | -7.31 70.24% | -10.47 43.30% | -3.40 67.54% | -1.89 44.47% | -0.91 51.89% | |
payables turnover | |||||||
receivables turnover | 2.93 - | 5.68 93.86% | |||||
research and ddevelopement to revenue | 6.61 - | 5.74 13.18% | |||||
return on tangible assets | -0.71 - | -0.51 27.85% | -0.37 27.48% | -0.86 132.78% | -0.82 4.53% | -1.15 40.44% | |
revenue per share | 1.46 - | 0.53 63.62% | |||||
roe | 0.72 - | 0.54 26.01% | -0.40 174.13% | -1.04 161.63% | -0.97 7.16% | -1.51 56.40% | |
roic | 0.73 - | 0.58 19.41% | 3.58 513.14% | -2.70 175.32% | 1.19 144.07% | 2.10 76.82% | |
sales general and administrative to revenue | 2.03 - | 1.97 3.20% | |||||
shareholders equity per share | -7.09 - | -15.01 111.78% | 24.24 261.43% | 3.20 86.78% | 2.17 32.16% | 0.66 69.64% | |
stock based compensation to revenue | 0.24 - | 0.35 43.99% | |||||
tangible asset value | -26.34M - | -55.79M 111.78% | 82.88M 248.56% | 42.16M 49.14% | 52.29M 24.03% | 31.21M 40.31% | |
tangible book value per share | -7.09 - | -15.01 111.78% | 24.24 261.43% | 3.20 86.78% | 2.17 32.16% | 0.66 69.64% | |
working capital | 21.68M - | 46.49M 114.42% | 82.58M 77.63% | 41.45M 49.80% | 51.57M 24.41% | 30.11M 41.62% |
All numbers in USD (except ratios and percentages)